CCT2 and breast carcinoma: Consistent with these observations, our study revealed increased levels of p-JAK2 and p-STAT3 in CCT2-overexpressing breast cancer cells, indicating that CCT2 drives breast cancer progression via JAK2/STAT3 pathway activation.